0001104659-18-060326.txt : 20181105 0001104659-18-060326.hdr.sgml : 20181105 20181003161609 ACCESSION NUMBER: 0001104659-18-060326 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20181003 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerecor Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 400 E. PRATT ST. STREET 2: SUITE 606 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 400 E. PRATT ST. STREET 2: SUITE 606 CITY: BALTIMORE STATE: MD ZIP: 21202 CORRESP 1 filename1.htm

 

 

400 E. Pratt Street, Suite 606

Baltimore, Maryland 21202

 

October 3, 2018

 

 

VIA EDGAR

 

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street N.E.

Washington, DC 20549

Attn:  Dorie Yale

 

Re:                             Cerecor Inc.

Registration Statement on Form S-3

Filed September 7, 2018, as amended October 2, 2018

File No. 333-227227

 

Ladies and Gentlemen:

 

Cerecor Inc., a Delaware corporation (the “Registrant”), hereby requests that the Securities and Exchange Commission take appropriate action to make the Registration Statement on Form S-3 (File No. 333-227227) effective as of 4:30 p.m. Eastern Time, Friday, October 5, 2018, or as soon thereafter as practicable. Please advise our corporate counsel, Alexander M. Donaldson at (919) 781-4000, of any questions.

 

The Registrant understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.

 

 

Very truly yours,

 

 

 

CERECOR INC.

 

 

 

 

 

 

By:

/s/ Joseph Miller

 

 

Name: Joseph Miller

 

 

Title: Chief Financial Officer

 

 GRAPHIC 2 g270952bqi001.jpg GRAPHIC begin 644 g270952bqi001.jpg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end